An overview of uterine cancer and its management
- PMID: 16375642
- DOI: 10.1586/14737140.6.1.33
An overview of uterine cancer and its management
Abstract
Endometrial cancer is increasingly common in affluent Western countries, largely owing to the growing obesity of those populations. There are two recognized types of endometrial cancer: Type I is more common and is associated with obese postmenopausal women and comprises approximately 80% of all endometrial cancers; Type II describes a woman who is often younger and thinner with a more aggressive histologic type that is nonestrogen dependent, of either serous or clear cell histology, and consists of a more aggressive clinical course and results in poorer prognosis. As the majority of patients with endometrial cancer present with symptoms and have early disease, screening is unlikely to be cost effective or reduce the mortality rate. However, surveillance of high-risk populations is a different proposition. Patients who may benefit from routine surveillance include those with a family history of endometrial cancer, a history of hormone replacement therapy with less than 12-14 days of progestogens, long-term use of tamoxifen, hereditary nonpolyposis colorectal cancer family syndrome, Cowden's syndrome, Peutz-Jeghers syndrome, a history of breast cancer and obesity. Most patients with endometrial cancer are offered surgery as first-line therapy. The standard surgical procedure should be an extrafascial total hysterectomy with bilateral salpingo-oophorectomy. Adnexal removal is also recommended, even if the adnexa appear normal, as they may contain micrometastases. The safety of a laparoscopic approach in the surgical management of uterine cancer has not yet been demonstrated in prospective randomized trials, therefore, the field awaits the Gynaecologic Oncology Group's prospective Lap-2 study. While post-treatment follow-up guidelines vary between institutions and countries, in general, patients at high risk of recurrence are followed closely every 3-4 months for the first year or two, then every 6 months to complete 5 years of follow-up.
Similar articles
-
Endometrial cancer and its management.Womens Health (Lond). 2007 Jan;3(1):45-54. doi: 10.2217/17455057.3.1.45. Womens Health (Lond). 2007. PMID: 19803864
-
[Surgical therapy of endometrial cancer].Zentralbl Gynakol. 1987;109(7):432-7. Zentralbl Gynakol. 1987. PMID: 3617990 German.
-
Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.Obstet Gynecol. 2007 Jul;110(1):18-25. doi: 10.1097/01.AOG.0000267500.27329.85. Obstet Gynecol. 2007. PMID: 17601891
-
[Endometrial cancer in HNPCC syndrome].J Gynecol Obstet Biol Reprod (Paris). 2008 Oct;37(6):547-53. doi: 10.1016/j.jgyn.2008.05.010. Epub 2008 Jul 22. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 18650032 Review. French.
-
Uterine artery embolization as a treatment option for uterine myomas.Obstet Gynecol Clin North Am. 2006 Mar;33(1):125-44. doi: 10.1016/j.ogc.2005.12.009. Obstet Gynecol Clin North Am. 2006. PMID: 16504811 Review.
Cited by
-
Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients.Cancers (Basel). 2023 Jul 28;15(15):3832. doi: 10.3390/cancers15153832. Cancers (Basel). 2023. PMID: 37568650 Free PMC article.
-
Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2.Curr Oncol. 2022 Mar 21;29(3):2132-2140. doi: 10.3390/curroncol29030172. Curr Oncol. 2022. PMID: 35323372 Free PMC article. Review.
-
Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?Cancers (Basel). 2022 Feb 1;14(3):759. doi: 10.3390/cancers14030759. Cancers (Basel). 2022. PMID: 35159024 Free PMC article. Review.
-
The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers.Int J Mol Sci. 2020 Jul 16;21(14):5034. doi: 10.3390/ijms21145034. Int J Mol Sci. 2020. PMID: 32708748 Free PMC article. Review.
-
Epidemiological aspects of the outcomes from the treatment of endometriosis: Experience from two different geographical areas.Exp Ther Med. 2020 Feb;19(2):1079-1083. doi: 10.3892/etm.2019.8296. Epub 2019 Dec 5. Exp Ther Med. 2020. PMID: 32010272 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous